Biopharmaceutical manufacturers’ at-risk day is coming. Here’s how to prepare.
Amy Hampton
Advertisement
Articles by Amy Hampton
Advertisement
Latest Updated Articles
- Three tools for successful risk-based pharma negotiations
Published: October 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA Accepts NDA for Investigational Maintenance Asthma Treatment
2
Sponsored: The Teva Biosimilars Trend Report
3
The 6-Year Cure Threshold: Redefining Cure for Colon Cancer Survivors
4
Topical Ruxolitinib Cream Rapidly Repigments Vitiligo Lesions, Study Finds
5
